Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook
Go back to Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook| Merck & Co. (NYSE: MRK) | Delayed: 144.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.91 | 52 Week High | $65.46 | |||
| Open | $144.91 | 52 Week Low | $47.97 | |||
| Day High | $144.91 | P/E | 98.58 | |||
| Day Low | $144.91 | EPS | $1.47 | |||
| Volume | 12,484 | |||||

